Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis.

Shu Zhao,Minhang Zhou,Peng Wang,Jing Yang,Dong Zhang,Fan Yin,Peng Song

Technology in Cancer Research & Treatment（2022）

Cited 1|Views6
No score
Key words
hepatocellular carcinoma,lenvatinib,nivolumab,programmed death 1 inhibitors,sorafenib,toripalimab,transarterial chemoembolization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined